Longeveron Competitors and Similar CompaniesClear all
Longeveron's competitors and similar companies include Cynata Therapeutics, VALANX Biotech, Gelmetix and Integra.
 Longeveron Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. |  Cynata Therapeutics Cynata Therapeutics is a stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology. |  VALANX Biotech VALANX Biotech is a company that provides technology for site-specific protein conjugation with a focus on the therapeutics, diagnostics, and biocatalysis sectors. |  Gelmetix Gelmetix (formerly Gelexir Healthcare) is a company that provides solutions for treatment of chronic lower back pain caused by the degeneration of intervertebral discs. |  Integra Integra is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions. | |
Founding Date | Founding Date 2014 | Founding Date 2011 | Founding Date 2017 | Founding Date 2012 | Founding Date 1989 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Miami, US HQ | Locations Carlton, AU HQ Cremorne, AU Hawthorn, AU | Locations HQ | Locations Harrogate, GB HQ | Locations Jerusalem, IL HQ |
Employees | Employees 259% increase | Employees N/A | Employees 157% increase | Employees 8 | Employees 7 |
Valuation ($) | Valuation ($) 31.4 m | Valuation ($) 33.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $396k (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $803k (FY, 2025) | Gross profit $1.9m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($22.7m) (FY, 2025) | Net income ($9.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 168.1k (almost 9 years ago) | Latest funding round $ 4.6m (over 10 years ago) | Latest funding round $ 25m (over 8 years ago) |
Total funding raised | Total funding raised $ 9m | Total funding raised $ 14.1m | Total funding raised $ 268.1k | Total funding raised $ 6.2m | Total funding raised $ 28m |
For sources of this data, please see the company profile
View Company Profiles
Cynata Therapeutics
HQ
Carlton, AU
Cynata Therapeutics is a stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology.
View companyVALANX Biotech
HQ
Employees
15↑ 7% increase
VALANX Biotech is a company that provides technology for site-specific protein conjugation with a focus on the therapeutics, diagnostics, and biocatalysis sectors.
View companyGelmetix
HQ
Harrogate, GB
Employees
8
Gelmetix (formerly Gelexir Healthcare) is a company that provides solutions for treatment of chronic lower back pain caused by the degeneration of intervertebral discs.
View companyIntegra
HQ
Jerusalem, IL
Employees
7
Integra is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions.
View company